Subtype
Bladder Neoplasm
CI-CAN-00001978Explore in graph →
Non-malignant390 active trials10 approved drugs25 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001978Explore in graph →
Clinical trials
1,702 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02438865 | Prophylactic Intravesical Chemotherapy After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: a Randomized Controlled Trial Between Single Postoperative Dose Versus Maintenance Therapy. | completed | Phase 2 | 74 | Mansoura UniversityOTHER | 1 | Sep 13, 2018 | clinicaltrials |
| NCT02145390 | Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy | terminated | N/A | 1 | University of MiamiOTHER | 1 | Aug 28, 2018 | clinicaltrials |
| NCT00578526 | SU011248 for Platinum-Refractory Urothelial Cancer Evaluation Trial(SPRUCE) | completed | Phase 2 | 64 | AHS Cancer Control AlbertaOTHER | 1 | Aug 22, 2018 | clinicaltrials |
| NCT02700724 | Observation Versus Immediate Surgery of Low Risk Bladder Cancer | terminated | N/A | 8 | Vanderbilt University Medical CenterOTHER | 1 | Aug 13, 2018 | clinicaltrials |
| NCT02745301 | Urinary Biomarkers in the Detection of Urothelial Carcinoma of the Bladder | completed | — | 50 | Vanderbilt UniversityOTHER | 1 | Aug 13, 2018 | clinicaltrials |
| NCT00310011 | Gemcitabine, Paclitaxel, and Cisplatin in Treating Patients With Advanced Cancer of the Urothelium | completed | Phase 2 | 71 | Wake Forest University Health SciencesOTHER | 1 | Aug 10, 2018 | clinicaltrials |
| NCT01706185 | Incidence of Expression of Tumor Antigens in Cancer Tissue From Patients With Pathologically Demonstrated Bladder Cancer | completed | — | 156 | GlaxoSmithKlineINDUSTRY | 1 | Jul 31, 2018 | clinicaltrials |
| NCT00112671 | Sorafenib in Treating Patients With Advanced or Metastatic Cancer of the Urinary Tract | completed | Phase 2 | 17 | National Cancer Institute (NCI)NIH | 1 | Jul 27, 2018 | clinicaltrials |
| NCT03597087 | The Difference of Two Year Recurrence Rate According to Anesthetic Method During Transurethral Resection of Bladder Mass in Patients With Non-muscle Invasive Bladder Cancer: Prospective, Randomized, Clinical Phase II Study | unknown | N/A | 289 | Seoul National University HospitalOTHER | 1 | Jul 24, 2018 | clinicaltrials |
| NCT00089128 | Gemcitabine and Irinotecan in Treating Patients With Locally Advanced or Metastatic Bladder Cancer | terminated | Phase 2 | 16 | Medical University of South CarolinaOTHER | 1 | Jul 12, 2018 | clinicaltrials |
| NCT00268450 | Cisplatin, Bevacizumab, and Gemcitabine Followed by Surgery, Bevacizumab, and Paclitaxel in Treating Patients With Locally Advanced Nonmetastatic Bladder Cancer That Can Be Removed By Surgery | terminated | Phase 2 | 21 | Medical University of South CarolinaOTHER | 1 | Jul 12, 2018 | clinicaltrials |
| NCT00900276 | Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants | completed | — | 5 | Wake Forest University Health SciencesOTHER | 1 | Jul 5, 2018 | clinicaltrials |
| NCT02560584 | A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting | completed | Phase 3 | 304 | PhotocureINDUSTRY | 1 | Jul 2, 2018 | clinicaltrials |
| NCT03052504 | Prospective Versus Retrospective Complications in Radical Cystectomy and Nephrectomy | completed | — | 156 | Jørgen Bjerggaard JensenOTHER | 1 | Jun 27, 2018 | clinicaltrials |
| NCT03563443 | Genomic Imprinting Testing for Diagnosis of Bladder Cancer | unknown | — | 300 | Changhai HospitalOTHER | 1 | Jun 20, 2018 | clinicaltrials |
| NCT00055601 | Combination Chemotherapy and Radiation Therapy With/Without Surgery In Patients With Stage II/III Bladder Cancer | completed | Phase 2 | 97 | Radiation Therapy Oncology GroupNETWORK | 1 | Jun 15, 2018 | clinicaltrials |
| NCT00790569 | Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking | completed | N/A | 315 | Butler HospitalOTHER | 1 | Jun 6, 2018 | clinicaltrials |
| NCT03013894 | Confocal Laser Endomicroscopy in the Lower Urinary Tract | completed | — | 73 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Jun 6, 2018 | clinicaltrials |
| NCT03106610 | Trial of Anti-PD-1 (Nivolumab) in Bladder Cancer Patients Recently Treated With Intravesical BCG Immunotherapy | terminated | Phase 1 | 1 | M.D. Anderson Cancer CenterOTHER | 1 | May 24, 2018 | clinicaltrials |
| NCT02471495 | RITE-EUROPE (Radiofrequency-Induced Thermochemotherapy Effect-EUROPE) | withdrawn | Phase 3 | 0 | Medical Enterprises Europe B.V.INDUSTRY | 0 | May 7, 2018 | clinicaltrials |
| NCT00963404 | Image-Guided Tumorboost of Bladder Cancer | completed | Phase 1 / Phase 2 | 19 | University of AarhusOTHER | 1 | May 3, 2018 | clinicaltrials |
| NCT02543645 | A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer | terminated | Phase 1 | 18 | Celldex TherapeuticsINDUSTRY | 1 | Apr 30, 2018 | clinicaltrials |
| NCT01180478 | Comparison Study of Narrow Band Imaging Versus White Light Resection in Patients With Bladder Tumors/Cancer | completed | N/A | 965 | Clinical Research Office of the Endourological SocietyOTHER | 0 | Apr 25, 2018 | clinicaltrials |
| NCT01331824 | Trial of Amrubicin as Second-Line Therapy in Patients With Advanced/Metastatic Refractory Urothelial Carcinoma | terminated | Phase 2 | 22 | Matthew GalskyOTHER | 1 | Apr 23, 2018 | clinicaltrials |
| NCT01918592 | PET/MRI and Biomarkers in Bladder Cancer(ACEBIB) | completed | N/A | 25 | Turku University HospitalOTHER_GOV | 1 | Apr 18, 2018 | clinicaltrials |
| NCT02805608 | uPAR PET/CT and FDG PET/MRI for Preoperative Staging of Bladder Cancer | unknown | Phase 2 | 40 | Rigshospitalet, DenmarkOTHER | 1 | Apr 11, 2018 | clinicaltrials |
| NCT03390127 | Effect of PEEP on Arterial Oxygen Partial Pressure in Elderly Patients With Lithotomy Position Using LMA Supreme™ | completed | N/A | 68 | Asan Medical CenterOTHER | 1 | Apr 6, 2018 | clinicaltrials |
| NCT02977143 | Positive End-expiratory Pressure-induced Increase in Central Venous Pressure as a Predictor of Fluid Responsiveness in Robot-assisted Laparoscopic Surgery | completed | N/A | 50 | Seoul National University HospitalOTHER | 1 | Apr 3, 2018 | clinicaltrials |
| NCT01836978 | Prehabilitation to Enhance Postoperative Functional Capacity Following Radical Cystectomy | completed | N/A | 70 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Mar 22, 2018 | clinicaltrials |
| NCT02214602 | Value of Immediate Post-operative Intravesical Epirubicin in Intermediate&High Risk Non Muscle Invasive Bladder Cancer(NMIBCIVT) | completed | Phase 4 | 240 | Mansoura UniversityOTHER | 1 | Mar 22, 2018 | clinicaltrials |
| NCT01259063 | RAD001 and Intravesical Gemcitabine in BCG-Refractory Primary or Secondary Carcinoma In Situ of the Bladder | completed | Phase 1 / Phase 2 | 33 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 13, 2018 | clinicaltrials |
| NCT03464032 | A Study of BCD-135 in Patients With Advanced Solid Tumors | unknown | Phase 1 | 30 | BiocadINDUSTRY | 1 | Mar 13, 2018 | clinicaltrials |
| NCT01637935 | Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II Diabetes | completed | — | 193,099 | TakedaINDUSTRY | 0 | Mar 7, 2018 | clinicaltrials |
| NCT02841904 | The Accuracy of Optic Biopsies Versus Conventional Biopsies for the Diagnosis of Superficial Bladder Neoplasia | unknown | N/A | 189 | Herlev HospitalOTHER | 1 | Mar 6, 2018 | clinicaltrials |
| NCT01446822 | Safety Study of Bipolar Versus Monopolar Transurethral Resection of Bladder Tumors | completed | N/A | 44 | Daniel Stephan EngelerOTHER | 1 | Mar 5, 2018 | clinicaltrials |
| NCT01710293 | Intervention Protocol for Automated Point-of-Care Surveillance of Outpatient Delays in Cancer Diagnosis(PACT CREATE 3) | withdrawn | N/A | 0 | VA Office of Research and DevelopmentFED | 1 | Feb 26, 2018 | clinicaltrials |
| NCT02328417 | Enhanced Recovery After Radical Cystectomy Study | completed | — | 241 | Carlos LlorenteOTHER | 1 | Feb 22, 2018 | clinicaltrials |
| NCT02845050 | Phase Ib/II Study Assessing the Neo-adjuvant Combination Therapy of Vinflunine With Cisplatin Followed by Radical Cystectomy in Patients With Muscle-invasive Bladder Cancer (JaNEO)(JaNEO) | withdrawn | Phase 1 / Phase 2 | 0 | Ligartis GmbHINDUSTRY | 1 | Feb 13, 2018 | clinicaltrials |
| NCT03427034 | Assessment of BladderLight SurvEILlance(ABSEIL) | unknown | Phase 2 / Phase 3 | 2,100 | Cambridge University Hospitals NHS Foundation TrustOTHER | 0 | Feb 9, 2018 | clinicaltrials |
| NCT01090466 | Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium | completed | Phase 1 / Phase 2 | 15 | Cardiff UniversityOTHER | 1 | Feb 6, 2018 | clinicaltrials |
| NCT01826097 | Improving Sensitivity of Urine Cytology for Bladder Cancer | withdrawn | N/A | 0 | Johns Hopkins UniversityOTHER | 1 | Feb 1, 2018 | clinicaltrials |
| NCT03409029 | A Study Using MRI To Assess Bladder Motion During Radiotherapy | unknown | N/A | 20 | The Christie NHS Foundation TrustOTHER | 0 | Jan 30, 2018 | clinicaltrials |
| NCT01215071 | Eingeschränkte vs Ausgedehnte Lymphadenektomie LEA | completed | N/A | 401 | Association of Urologic Oncology (AUO)OTHER | 1 | Jan 24, 2018 | clinicaltrials |
| NCT01261299 | Clinical Study of Microdosing Carboplatin in Lung or Bladder Cancer | terminated | Early Phase 1 | 21 | University of California, DavisOTHER | 1 | Jan 9, 2018 | clinicaltrials |
| NCT03148158 | Assessment Of Bladder Tumors Stage And Grade By Outpatient Flexible Cystoscopy Performed By Urology Resident | unknown | — | 300 | Mansoura UniversityOTHER | 1 | Jan 9, 2018 | clinicaltrials |
| NCT02514408 | Circulating Tumor Cells in Operative Blood in Patients With Bladder Cancer | withdrawn | — | 0 | University of Southern CaliforniaOTHER | 0 | Jan 2, 2018 | clinicaltrials |
| NCT03238664 | Robot-Assisted Laparoscopic High-Intensity Focused Ultrasound and Radical Cystectomy for Thermal Ablation of Muscle Invasive Cells in Patients With Bladder Tumors | withdrawn | N/A | 0 | University of Southern CaliforniaOTHER | 0 | Jan 2, 2018 | clinicaltrials |
| NCT01469221 | Efficacy and Safety Study of Apaziquone vs. Placebo in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC) | terminated | Phase 3 | 47 | Spectrum Pharmaceuticals, IncINDUSTRY | 4 | Dec 15, 2017 | clinicaltrials |
| NCT00461851 | Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-naive Patients With Advanced/Metastatic Bladder Carcinoma | completed | Phase 2 | 17 | Yale UniversityOTHER | 1 | Dec 14, 2017 | clinicaltrials |
| NCT01567462 | PlasmaKinetic (PK) Button Vaporization Electrode for Treatment of Bladder Tumors(PK Button) | completed | N/A | 95 | Emory UniversityOTHER | 1 | Dec 8, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Sep 13, 2018source: clinicaltrials